Inventor · disambiguated record
Deqiang Niu
Also filed as: NIU DEQIANG
82 granted patents·34 pending applications·1,495 citations·filing 2001–2023
99Inventor score
Files withCELGENE CAR LLC30CELGENE AVILOMICS RES INC21ENANTA PHARM INC17NIU DEQIANG13ARTIVILA BIOPHARMA4
Top patents by PatentIndex Score
116 records- 0199US8609679B22,4-diaminopyrimidines useful as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Dec 17, 2013·84 cites·4 claims
- 0298US8710222B22,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Apr 29, 2014·52 cites·3 claims
- 0398US8450335B22,4-disubstituted pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2009·Granted May 28, 2013·130 cites·22 claims
- 0498US8338439B22,4-disubstituted pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2009·Granted Dec 25, 2012·175 cites·2 claims
- 0598US7635683B2Quinoxalinyl tripeptide hepatitis C virus inhibitorsENANTA PHARM INC·Filed 2006·Granted Dec 22, 2009·75 cites·5 claims
- 0697US9987276B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE CAR LLC·Filed 2016·Granted Jun 5, 2018·23 cites·26 claims
- 0797US8975249B2Heterocyclic compounds and uses thereofLEE KWANGHO·Filed 2011·Granted Mar 10, 2015·57 cites·25 claims
- 0897US7605126B2Acylaminoheteroaryl hepatitis C virus protease inhibitorsENANTA PHARM INC·Filed 2006·Granted Oct 20, 2009·38 cites·15 claims
- 0997US7582605B2Phosphorus-containing hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2006·Granted Sep 1, 2009·59 cites·9 claims
- 1097US7273853B26-11 bicyclic ketolide derivativesENANTA PHARM INC·Filed 2005·Granted Sep 25, 2007·35 cites·29 claims
- 1196US10577380B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2019·Granted Mar 3, 2020·10 cites·4 claims
- 1296US9561228B2ERK inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Feb 7, 2017·37 cites·17 claims
- 1396US9375431B22,4-disubstituted pyrimidine compounds useful as kinase inhibtorsCELGENE AVILOMICS RES INC·Filed 2015·Granted Jun 28, 2016·21 cites·29 claims
- 1496US9212181B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Dec 15, 2015·34 cites·42 claims
- 1596US8796255B2Mutant-selective EGFR inhibitors and uses thereofLEE KWANGHO·Filed 2011·Granted Aug 5, 2014·40 cites·9 claims
- 1696US7687459B2Arylalkoxyl hepatitis C virus protease inhibitorsENANTA PHARM INC·Filed 2007·Granted Mar 30, 2010·26 cites·18 claims
- 1796US7189704B26-11 bicyclic ketolide derivativesENANTA PHARM INC·Filed 2005·Granted Mar 13, 2007·15 cites·22 claims
- 1895US10010548B22,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE CAR LLC·Filed 2016·Granted Jul 3, 2018·15 cites·4 claims
- 1995US9409921B22,4-disubstituted pyrimidines as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2014·Granted Aug 9, 2016·25 cites·2 claims
- 2095US9296737B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Mar 29, 2016·27 cites·23 claims
- 2194US10253040B1MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2017·Granted Apr 9, 2019·12 cites·15 claims
- 2294US9867824B2Heterocyclic compounds and uses thereofCELGENE CAR LLC·Filed 2016·Granted Jan 16, 2018·11 cites·14 claims
- 2394US9458175B2MK2 inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2015·Granted Oct 4, 2016·16 cites·32 claims
- 2494US9145387B2ERK inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Sep 29, 2015·21 cites·28 claims
- 2594US7662779B2Triazolyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2007·Granted Feb 16, 2010·14 cites·16 claims
- 2693US9980964B2ERK inhibitors and uses thereofCELGENE CAR LLC·Filed 2017·Granted May 29, 2018·11 cites·28 claims
- 2793US9868723B2Mutant-selective EGFR inhibitors and uses thereofCELGENE CAR LLC·Filed 2016·Granted Jan 16, 2018·10 cites·16 claims
- 2893US9790235B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2016·Granted Oct 17, 2017·12 cites·18 claims
- 2993US9765038B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2016·Granted Sep 19, 2017·11 cites·20 claims
- 3093US9409887B2Mutant-selective EGFR inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Aug 9, 2016·16 cites·26 claims
- 3193US9238629B2Heteroaryl compounds and uses thereofLEE KWANGHO·Filed 2011·Granted Jan 19, 2016·18 cites·17 claims
- 3293US8980935B2HCV protease inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2013·Granted Mar 17, 2015·7 cites·26 claims
- 3393US8741837B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2012·Granted Jun 3, 2014·10 cites·23 claims
- 3493US8309685B2HCV protease inhibitors and uses thereofPETTER RUSSELL C·Filed 2009·Granted Nov 13, 2012·20 cites·36 claims
- 3593US6878691B26-11 bicyclic ketolide derivativesENANTA PHARM INC·Filed 2003·Granted Apr 12, 2005·73 cites·26 claims
- 3692US10081606B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2017·Granted Sep 25, 2018·8 cites·8 claims
- 3792US9504686B2ERK inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2015·Granted Nov 29, 2016·10 cites·40 claims
- 3892US9321786B2Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Apr 26, 2016·15 cites·51 claims
- 3992US8524760B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2012·Granted Sep 3, 2013·9 cites·13 claims
- 4092US8293705B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2009·Granted Oct 23, 2012·12 cites·15 claims
- 4192US8188137B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2009·Granted May 29, 2012·13 cites·29 claims
- 4291US9796700B2ERK inhibitors and uses thereofCELGENE CAR LLC·Filed 2016·Granted Oct 24, 2017·7 cites·17 claims
- 4391US8268776B2Macrocylic oximyl hepatitis C protease inhibitorsSUN YING·Filed 2008·Granted Sep 18, 2012·15 cites·27 claims
- 4490US11351168B12,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE CAR LLC·Filed 2020·Granted Jun 7, 2022·2 cites·3 claims
- 4590US10828300B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE CAR LLC·Filed 2018·Granted Nov 10, 2020·3 cites·27 claims
- 4690US10596172B22,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE CAR LLC·Filed 2018·Granted Mar 24, 2020·5 cites·3 claims
- 4789US11096942B2Heterocyclic compounds and uses thereofCELGENE CAR LLC·Filed 2019·Granted Aug 24, 2021·2 cites·14 claims
- 4889US10138256B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2014·Granted Nov 27, 2018·11 cites·12 claims
- 4989US7402568B2Bicyclic 9a-azalide derivativesENANTA PHARM INC·Filed 2005·Granted Jul 22, 2008·16 cites·22 claims
- 5088US10434101B2Heterocyclic compounds and uses thereofCELGENE CAR LLC·Filed 2018·Granted Oct 8, 2019·4 cites·17 claims
Showing the top 50 of 116 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Deqiang Niu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →